Evidence map›Paper›PMID 42798051›Full record

ReviewMedicine2026

Lymphocutaneous sporotrichosis: A case report from southeastern China and review of the literature.

Xiaoqing Wang, Jing Bian, Jianping Xu, Yaqing Li, Shujuan Ji, Li Qin, Qingsong Meng

Abstract readCase ReportsReview
In one paragraph

Review in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiaoqing WangDepartment of Infectious Disease, Hebei General Hospital, Shijiazhuang, China.ORCID 0000-0002-4713-6058
Jing BianDepartment of Infectious Disease, Hebei General Hospital, Shijiazhuang, China.
Jianping XuDepartment of Infectious Disease, Hebei General Hospital, Shijiazhuang, China.
Yaqing LiDepartment of Infectious Disease, Hebei General Hospital, Shijiazhuang, China.
Shujuan JiDepartment of Infectious Disease, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Li QinDepartment of Infectious Disease, Hebei General Hospital, Shijiazhuang, China.
Qingsong MengDepartment of Urology Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleSporotrichosis is a dermatomycosis caused by the dimorphic fungus Sporothrix schenckii sensu lato. The traditional gold standard for the definitive diagnosis of the disease is fungal culture. Our case describes the patient diagnosed lymphocutaneous sporotrichosis through the metagenomic next-generation sequencing (mNGS) quickly. PATIENT CONCERNS: A 53-year-old male presented with protracted multiple ulcerated lesions. The pathological analysis of his skin biopsy specimen was inflammatory reaction, routine hematological and biochemistry examinations, the imaging of heart, lung and stomach were normal. DIAGNOSES: The wounds were received debridement in our ward. Sporothrix schenckii was identified by the culture and the mNGS of the wound pus.

interventionsFollowing definitive diagnosis, oral itraconazole was administered to the patient; meanwhile, regular clinical follow-up visits and reevaluations were scheduled for continuous monitoring. OUTCOMES: The patient recovered well, and no signs of recurrence were detected during follow-up. LESSONS: This case illustrates that mNGS, as an emerging molecular biological diagnostic technique, holds significant diagnostic value for the rapid identification of sporotrichosis. Timely and accurate diagnosis is essential for achieving favorable clinical outcomes.

Indexed as

SporothrixSporotrichosisAntifungal AgentsChinaDebridementHigh-Throughput Nucleotide SequencingHumansItraconazoleMaleMiddle AgedAntifungal AgentsItraconazoleitraconazolelymphocutaneous sporotrichosismetagenomic next-generation sequencing (mNGS)

Identifiers

PMID42798051
PMCPMC13619261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.